1144 related articles for article (PubMed ID: 15147787)
1. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
[TBL] [Abstract][Full Text] [Related]
2. Effects of the antiestrogenic environmental pollutant 3,3',4,4', 5-pentachlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Sahlin L; Edlund M; Orberg J
Toxicol Appl Pharmacol; 1999 Feb; 154(3):236-44. PubMed ID: 9931283
[TBL] [Abstract][Full Text] [Related]
3. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
[TBL] [Abstract][Full Text] [Related]
5. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
6. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
Sahlin L; Masironi B; Akerberg S; Eriksson H
Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620
[TBL] [Abstract][Full Text] [Related]
7. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
8. The dioxin-like pollutant PCB 126 (3,3',4,4',5-pentachlorobiphenyl) affects risk factors for cardiovascular disease in female rats.
Lind PM; Orberg J; Edlund UB; Sjöblom L; Lind L
Toxicol Lett; 2004 May; 150(3):293-9. PubMed ID: 15110081
[TBL] [Abstract][Full Text] [Related]
9. Effects of hysterectomy on bone in intact rats, ovariectomized rats, and ovariectomized rats treated with estrogen.
Goulding A; Gold E; Lewis-Barned NJ
J Bone Miner Res; 1996 Jul; 11(7):977-83. PubMed ID: 8797119
[TBL] [Abstract][Full Text] [Related]
10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats.
Hertrampf T; Degen GH; Kaid AA; Laudenbach-Leschowsky U; Seibel J; Di Virgilio AL; Diel P
Planta Med; 2006 May; 72(6):484-7. PubMed ID: 16773530
[TBL] [Abstract][Full Text] [Related]
12. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
13. Modulation of intestinal estrogen receptor by ovariectomy, estrogen and growth hormone.
Chen C; Kalu DN
J Pharmacol Exp Ther; 1998 Jul; 286(1):328-33. PubMed ID: 9655876
[TBL] [Abstract][Full Text] [Related]
14. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
Han X; Xu Y; Wang J; Pei X; Yang R; Li N; Li Y
Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.
Diel P; Hertrampf T; Seibel J; Laudenbach-Leschowsky U; Kolba S; Vollmer G
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):60-70. PubMed ID: 17049845
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
17. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
[TBL] [Abstract][Full Text] [Related]
19. Effects of daidzein, genistein, and 17beta-estradiol on 7,12-dimethylbenz[a]anthracene-induced mutagenicity and uterine dysplasia in ovariectomized rats.
Aidoo A; Bishop ME; Shelton SD; Lyn-Cook LE; Chen T; Manjanatha MG
Nutr Cancer; 2005; 53(1):82-90. PubMed ID: 16351510
[TBL] [Abstract][Full Text] [Related]
20. [One year observation on effects of estrogen, tamoxifen combined with or without fluoride on preventing bone loss in ovariectomized rats].
Liu H; Peng H; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):82-5. PubMed ID: 11953070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
